FR2196172A1 - Treatment of neoplasms - with 2,3,5,6-tetrahydro-6-phenylimidazo(2,1-6)thiazole - Google Patents

Treatment of neoplasms - with 2,3,5,6-tetrahydro-6-phenylimidazo(2,1-6)thiazole

Info

Publication number
FR2196172A1
FR2196172A1 FR7330084A FR7330084A FR2196172A1 FR 2196172 A1 FR2196172 A1 FR 2196172A1 FR 7330084 A FR7330084 A FR 7330084A FR 7330084 A FR7330084 A FR 7330084A FR 2196172 A1 FR2196172 A1 FR 2196172A1
Authority
FR
France
Prior art keywords
phenylimidazo
neoplasms
thiazole
tetrahydro
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7330084A
Other languages
French (fr)
Other versions
FR2196172B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of FR2196172A1 publication Critical patent/FR2196172A1/en
Application granted granted Critical
Publication of FR2196172B1 publication Critical patent/FR2196172B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The regression of neoplasms of all kinds is promoted by the systematic administration of an effective amt. of 2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b] thiazole or its acid-addn. salt in a pharmaceutical carrier.
FR7330084A 1972-08-17 1973-08-17 Treatment of neoplasms - with 2,3,5,6-tetrahydro-6-phenylimidazo(2,1-6)thiazole Granted FR2196172A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28136772A 1972-08-17 1972-08-17

Publications (2)

Publication Number Publication Date
FR2196172A1 true FR2196172A1 (en) 1974-03-15
FR2196172B1 FR2196172B1 (en) 1976-08-13

Family

ID=23076983

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7330084A Granted FR2196172A1 (en) 1972-08-17 1973-08-17 Treatment of neoplasms - with 2,3,5,6-tetrahydro-6-phenylimidazo(2,1-6)thiazole

Country Status (5)

Country Link
BE (1) BE803718A (en)
DE (1) DE2340632C2 (en)
FR (1) FR2196172A1 (en)
PH (1) PH9277A (en)
ZA (1) ZA735606B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2395754A1 (en) * 1977-06-28 1979-01-26 Johnson & Johnson COMPOSITION BASED ON LEVAMISOLE OR DERIVATIVES OF THIS COMPOUND, FOR THE TOPICAL TREATMENT OF SCABIES
WO1992015297A1 (en) * 1991-02-28 1992-09-17 Janssen Pharmaceutica N.V. Agents, especially levamisole, against the human immunodeficiency virus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642809A (en) * 1965-10-05 1972-02-15 American Cyanamid Co Method for producing 2 3 5 6-tetra hydroimidazo-(2 1-b)thiazoles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131034C (en) * 1964-05-11

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642809A (en) * 1965-10-05 1972-02-15 American Cyanamid Co Method for producing 2 3 5 6-tetra hydroimidazo-(2 1-b)thiazoles

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2395754A1 (en) * 1977-06-28 1979-01-26 Johnson & Johnson COMPOSITION BASED ON LEVAMISOLE OR DERIVATIVES OF THIS COMPOUND, FOR THE TOPICAL TREATMENT OF SCABIES
WO1992015297A1 (en) * 1991-02-28 1992-09-17 Janssen Pharmaceutica N.V. Agents, especially levamisole, against the human immunodeficiency virus

Also Published As

Publication number Publication date
AU5910573A (en) 1975-02-13
PH9277A (en) 1975-08-05
DE2340632A1 (en) 1974-02-28
DE2340632C2 (en) 1985-09-05
FR2196172B1 (en) 1976-08-13
ZA735606B (en) 1975-04-30
BE803718A (en) 1973-12-17

Similar Documents

Publication Publication Date Title
FI52221C (en) Process for the preparation of antibacterial 1,4-dihydro-4-oxo-7-pyridyl-3-quinolinecarboxylic acid derivatives.
CA968474A (en) Treatment of nitrogenous effluents
OA04560A (en) 2-disubstituted 1-oxo-5-indanyloxy- (or thio) -alkanoic acids.
CA1011734A (en) Process for the manufacture of insulin, analogs and derivatives thereof
CA1007232A (en) Method for the making of cyclic compounds with urea grouping
FI52863C (en) A new process for the preparation of piperazine morphanthridine, piperazine dibenzooxines, sepine, thiazepine and diazepine derivatives.
FR2196172A1 (en) Treatment of neoplasms - with 2,3,5,6-tetrahydro-6-phenylimidazo(2,1-6)thiazole
NL7415792A (en) CEPHALOSPORIN AND PENICILLIN DERIVATIVES.
FI52347C (en) Process for the preparation of 21-pregnanoic acid derivatives.
GB1404708A (en) Imidazo 2,1-b thiazole derivatives
NL7314889A (en) TREATMENT OF E-CAPROLACTAM WITH A MICRO-ORGANISM.
NL7414467A (en) PROCESS FOR THE PREPARATION OF 2,4-DIOXO-1-PY-RIMIDINYL PENICILIN AND CEPHALOSPORIN DERIVATIVES.
NL7509191A (en) PROCESS FOR THE PREPARATION OF ANTIBIOTICS.
NL158704B (en) PROCESS FOR THE PREPARATION OF Aqueous, Anti-discoloration-Stable SOLUTIONS OF BASIC ANTIBIOTICS.
FI51207C (en) Process for the preparation of rifamycin B.
SU483316A1 (en) Scraper conveyor body
FI49501C (en) Process for the preparation of antibacterial active N-vinylquinols.
IL43065A0 (en) The preparation of penicillin sulfoxide
FI52095C (en) Process for the preparation of an aqueous solution of left-handed 6-phenyl-2,3,5,6-tetrahydroimidazo [2,1-b] thiazole hydrochloride.
FR2327240A1 (en) PROCESS FOR THE PREPARATION OF 2,3,4,5,6,7-HEXAHYDROCYCLOPENTA- (E) -1,3-OXAZINE-2,4-DIONES
NL150119B (en) PROCESS FOR THE PREPARATION OF STABLE GLYCOPEPTIDE ANTIBIOTICS.
NO740041L (en) Analogous process for the preparation of pharmacologically active pyrimidopyrimidines.
CA985685A (en) Process for the preparation of 2-amino-4,5-dihydropyridine derivatives and compounds thereby produced
CA996928A (en) Compounds of the androstane series having anaesthetic activity
AU483138B2 (en) New imidazo[2,1-b] thiazole derivatives